Navigation Links
Perrigo Announces Approval for Over-the-Counter Children's Cetirizine Oral Solution
Date:4/14/2008

ALLEGAN, Mich., April 14 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC) Children's Cetirizine Hydrochloride Oral Solution (Allergy) and Children's Cetirizine Hydrochloride Oral Solution (Hives-Relief), 1mg/mL.

The product will be marketed under store brand labels and is comparable to McNeil Consumer Healthcare's Children's Zyrtec(R) Oral Solution, 1mg/mL, indicated for indoor and outdoor allergy and hives relief. According to Wolters Kluwer data, brand sales for the original prescription strength version of the product for the last 12 months ending December 2007 were approximately $80 million.

Perrigo's Chairman and CEO Joseph C. Papa stated, "This approval reflects our strategy to be first to market with the important products that make quality healthcare more affordable for our customers."

The Company expects to begin shipping the product immediately.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of th
'/>"/>

SOURCE Perrigo Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) ... received a written notice (the "Notice") executed by the ... of the Company, requesting that the Board of Directors ... for stockholder action by written consent relating to the ... director seat resulting from Ronald J. Kanterman,s departure (the ...
(Date:12/15/2009)... 15 SRI International, an independent nonprofit ... of U.S. patent 7,592,021 for a new bioadhesive ... drugs through the human body,s mucous membranes. This ... allows for a much longer release time compared ... Transmucosal delivery is an effective means to introduce ...
(Date:12/15/2009)... KNOXVILLE, Tenn., Dec. 15 Medical researchers ... attention with their revolutionary new technology for a ... ,, Following the success of its ... filed a patent on the biomarker, CA11-19, and ... inexpensive blood test, ColoMarker(TM) will detect colon cancer ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Stanford study recommends change in treating pulmonary embolisms 60161 1Stanford study recommends change in treating pulmonary embolisms 60161 2Stanford study recommends change in treating pulmonary embolisms 60161 3Stanford study recommends change in treating pulmonary embolisms 60161 4Vegetables can protect unborn child against diabetes 10545 1Vegetables can protect unborn child against diabetes 10545 2Stanford researchers awarded 246 27 million to study energy efficiency and human behavior 10541 1Stanford researchers awarded 246 27 million to study energy efficiency and human behavior 10541 2
(Date:12/16/2009)... SEATTLE, Dec. 16 For ages, people from ... its therapeutic properties. Its soothing waters have a reputation ... cites its involvement with miracles. Now, with the introduction ... ), bathers can enjoy the legendary benefits of Dead ... bath salt lines contain all-natural Dead Sea salt and ...
(Date:12/16/2009)... than in the ,70s, study finds , , TUESDAY, Dec. ... in the United States than it was more than ... , Researchers compared National Health and Nutrition Examination Survey ... to 1972 and from 8,339 black and white participants ... 54 years old. , The prevalence of myopia increased ...
(Date:12/16/2009)... visitors can earn a free 21-count one week trial bottle sample ... ... MI (PRWEB) December 16, 2009 -- ImmuneResponse247.com announces ... Sample” of Immune Response 247™ 6 Mushroom Formula , with ... Immune Response 247™ 6 Mushroom Formula is packaged in FDA approved ...
(Date:12/16/2009)... proud to announce being presented with the Weatherhead 100 Upstart Award ... growing companies in Northeast Ohio and is a testament to hard ... , ... (PRWEB) December 16, 2009 -- Request A ... 100 Upstart Award on December 3, 2009. The Weatherhead 100 ...
(Date:12/16/2009)... perfect gift to give that special woman who has everything? ... Mary Schook introduces exceptional beauty products online while educating the public ... ... (PRWEB) December 16, 2009 -- The holidays are rapidly approaching ... woman who has everything? Why stem cells, of course!, , , ...
Breaking Medicine News(10 mins):Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2
... variations in specific genes that metabolize vehicle emissions are ... near major roadways, a study led by researchers at ... found that children who carried variations in two genes ... were up to nine times more likely to develop ...
... with organ transplants, resigned to a lifetime of anti-rejection ... respite, say researchers at Lucile Packard Children,s Hospital and ... blood sample, the scientists have identified for the first ... small group of patients who beat the odds and ...
... Study finds a connection, but researchers aren,t sure why , , ... lose weight a decade or more before major symptoms appear, ... among individual women and can,t be used to diagnose who ... point to a long incubation time for dementia, said study ...
... A patients expectations about the side effects of chemotherapy ... side effects. Worries about severe allergic reactions to their ... study from the Lineberger Comprehensive Cancer Center at the ... Comprehensive Cancer Center and the Sarah Canon Cancer Center ...
... how Huntington,s disease (HD) is triggered. The research will ... Genetics, on Monday, August 20. , "These are exciting ... Scientific Director at the Canadian Institutes of Health Research, ... if the huntingtin protein has been known for almost ...
... report symptoms of anxiety, depression once back home , SUNDAY, ... of post-traumatic stress disorder (PTSD) was reported by about 20 ... during the Iraq War, says a University of Michigan study ... The women in the survey (74.2 percent enlisted, 25.8 percent ...
Other Medicine News:Health News:Genetic predisposition increases childhood asthma risk 2Health News:Study provides hope that some transplant patients could live free of antirejection drugs 2Health News:Study provides hope that some transplant patients could live free of antirejection drugs 3Health News:Early Weight Loss in Women Linked to Dementia 2Health News:Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US 2Health News:Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US 3Health News:A new molecular zip code, and a new drug target for Huntington's disease 2Health News:A new molecular zip code, and a new drug target for Huntington's disease 3Health News:Work-Family Conflict Dogs Air Force Women After Deployment 2
Hypervisor III Central Monitoring System...
... Central Monitoring System combines Invivo's AutoNet™ ... central monitoring and clinical information system ... monitoring features, including alarms, full disclosure ... connecting your patient to a bedside ...
The Panorama Central Station includes bi-directional communication with Datascope bedside monitors, optional 72 hours of disclosure and a touch screen user interface....
... List Editor) Multi-Channel Infusion System brings a ... instrument combines three independent infusion channels with ... unparalleled small size. Now with Advanced Dose ... simplifies the delivery of complex drug regimens. ...
Medicine Products: